Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Filings indexed 167 across all filing types
Latest filing 2017-02-24 Interim / Quarterly Rep…
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive quarterly financial report for MedCap AB, covering the period from November to January (Q3) and the nine-month period ending in January. It includes detailed financial statements, tables comparing current and prior year performance, management commentary (VD kommentar), and breakdowns by business segments (Medicinteknik, Specialistläkemedel, Läkemedelshandel). It contains substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report. 9M 2017
2017-02-24 Swedish
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding, specifically noting the 'Reason for major shareholding notification Buy' and providing precise figures for the number of shares (676,793) and the resulting percentage of voting rights (5.05%). This structure—reporting the 'Before' and 'After' transaction details regarding ownership thresholds—is characteristic of a Major Shareholding Notification. This aligns directly with the definition for 'Major Shareholding Notification' (Code: MRQ). The document is not a full annual report (10-K), an earnings release (ER), or a director's dealing (DIRS), but specifically concerns significant ownership changes.
2016-12-06 English
Interim / Quarterly Report 2016
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for MedCap AB covering the second quarter (August-October) and the first half-year (May-October) of the 2016/2017 fiscal year. It contains detailed financial statements, including income statements, cash flow data, balance sheet information, and management commentary on business segments (Medicinteknik, Specialistläkemedel, Läkemedelshandel). Since it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H2 2016
2016-11-30 Swedish
Extra Bolagsstämma MedCap den 28 oktober 2016
Regulatory Filings Classification · 1% confidence The document is a press release dated October 28, 2016, titled "Extra Bolagsstämma MedCap den 28 oktober 2016" (MedCap's Extraordinary General Meeting held on October 28, 2016). It details a decision made at this meeting regarding the acquisition of minority shares in Unimedic AB. Since it reports on a decision made at a general meeting (Extraordinary General Meeting), it relates to shareholder decisions. However, the core content is the outcome of a vote/decision made at a general meeting, which aligns best with Declaration of Voting Results & Voting Rights Announcements (DVA), although it is not explicitly stating the final vote tally, but rather the resolution passed. Given the context of an EGM decision, DVA is the most specific fit among the options related to shareholder meetings. It is too specific for a general Regulatory Filing (RNS) and does not fit ER, CT, or IR. It is a direct announcement of a corporate action decided by shareholders.
2016-10-28 Swedish
Resultatet för det andra kvartalet bedöms bli lägre än förväntat
Earnings Release Classification · 1% confidence The document is a press release dated October 24, 2016, titled "Resultatet för det andra kvartalet bedöms bli lägre än förväntat" (The result for the second quarter is assessed to be lower than expected). It specifically discusses the expected EBITDA for the second quarter (Q2) of the fiscal year 2016/2017, providing key figures (5 - 7 MSEK vs 18.3 MSEK previous year) and explaining the reasons for the deviation (inventory write-downs, lower sales volumes). This content aligns perfectly with an Earnings Release (ER), which is defined as the initial announcement of periodical financial results (key highlights only). It is not a comprehensive Interim Report (IR) or the full Annual Report (10-K). The mention of EU Market Abuse Regulation confirms it is a mandatory financial disclosure. Q2 2016
2016-10-24 Swedish
Kallelse till extra bolagsstämma i MedCap AB (publ) den 28 oktober 2016
AGM Information Classification · 1% confidence The document is titled "Kallelse till extra bolagsstämma i MedCap AB (publ)" which translates to 'Notice of Extraordinary General Meeting in MedCap AB (publ)'. It details the date, time, location, registration procedures, and the proposed agenda items for a shareholder meeting. This content directly relates to the formal process and materials surrounding a General Meeting, specifically an Extraordinary General Meeting (EGM). While the agenda includes voting items, the document itself is the official notice/call for the meeting, not the results (DVA) or the proxy solicitation materials (PSI). Since there is no specific code for an EGM Notice, and it is a formal announcement related to shareholder governance and meetings, it aligns best with the general category for AGM/Shareholder Meeting materials, which is AGM-R, as EGMs are a type of General Meeting.
2016-10-07 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.